Literature DB >> 15082473

How to diagnose axial spondyloarthropathy early.

N Barkham1, H Marzo-Ortega, D McGonagle, P Emery.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15082473      PMCID： PMC1755009          DOI： 10.1136/ard.2003.014589

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

Review 1.  The concept of disease modification in spondyloarthropathy.

Authors:  Helena Marzo-Ortega; Paul Emery; Dennis McGonagle
Journal:  J Rheumatol       Date:  2002-08       Impact factor: 4.666

2.  Clinical history as a screening test for ankylosing spondylitis.

Authors:  A Calin; J Porta; J F Fries; D J Schurman
Journal:  JAMA       Date:  1977-06-13       Impact factor: 56.272

3.  The outcome of ankylosing spondylitis: a study of 100 patients.

Authors:  J T Gran; J F Skomsvoll
Journal:  Br J Rheumatol       Date:  1997-07

4.  Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.

Authors:  J Braun; X Baraliakos; W Golder; J Brandt; M Rudwaleit; J Listing; M Bollow; J Sieper; D Van Der Heijde
Journal:  Arthritis Rheum       Date:  2003-04

5.  Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study.

Authors:  H Marzo-Ortega; D McGonagle; P O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2001-09

6.  The natural disease course of ankylosing spondylitis.

Authors:  S Carette; D Graham; H Little; J Rubenstein; P Rosen
Journal:  Arthritis Rheum       Date:  1983-02

7.  Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study.

Authors:  J Oostveen; R Prevo; J den Boer; M van de Laar
Journal:  J Rheumatol       Date:  1999-09       Impact factor: 4.666

8.  A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.

Authors:  Walter P Maksymowych; Gian S Jhangri; Avril A Fitzgerald; Sharon LeClercq; Peter Chiu; Alex Yan; Kenneth J Skeith; Stephen L Aaron; Joanne Homik; Paul Davis; Dale Sholter; Anthony S Russell
Journal:  Arthritis Rheum       Date:  2002-03

9.  How to diagnose axial spondyloarthritis early.

Authors:  M Rudwaleit; D van der Heijde; M A Khan; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

10.  Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis.

Authors:  K Lehtinen
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103
View more
  2 in total

Review 1.  The treatment of the rheumatological manifestations of the inflammatory bowel diseases.

Authors:  Melissa Padovan; Gabriella Castellino; Marcello Govoni; Francesco Trotta
Journal:  Rheumatol Int       Date:  2006-06-24       Impact factor: 2.631

2.  Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).

Authors:  Joachim Sieper; Désirée van der Heijde; Maxime Dougados; Philip J Mease; Walter P Maksymowych; Matthew A Brown; Vipin Arora; Aileen L Pangan
Journal:  Ann Rheum Dis       Date:  2012-07-07       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.